|
|
|
|
Emory Healthcare Clinical Trial
|
|
Mood and Anxiety Disorders Program
|
Summary
This study is designed to determine the effectiveness and safety of agomelatine, a new medication for the treatment of major depressive disorder.
|
Study Involves
|
Inclusion Criteria
Age: 18 and older
Sex: Men and Women
Ethnic Origin: All
Diagnosis required for participation: Major Depressive Disorder
|
Exclusion Criteria
|
Patient Involvement
|
Contact Information
| Name |
Work Telephone |
Email |
|
| Beverly A. Weaver, RN |
404-712-MOOD (6663) |
|
| , |
|
|
| , |
|
|
|
| |
|
|
